Gene · 4050
Papers2,481
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,481
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The artificial intelligence and machine learning in lung cancer immunotherapy. | J Hematol Oncol | 2023 | 37226190 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing of peripheral blood reveals immune cell dysfunction in premature ovarian insufficiency. | Front Endocrinol (Lausanne) | 2023 | 37223018 | PubTator, text mining | PubMed |
| Development and validation of a prognostic 15-gene signature for stratifying HER2+/ER+ breast cancer. | Comput Struct Biotechnol J | 2023 | 37216014 | PubTator, text mining | PubMed |
| Helicobacter pylori regulates stomach diseases by activating cell pathways and DNA methylation of host cells. | Front Cell Dev Biol | 2023 | 37215092 | PubTator, text mining | PubMed |
| Pathogenicity, tissue tropism and potential vertical transmission of SARSr-CoV-2 in Malayan pangolins. | PLoS Pathog | 2023 | 37196026 | PubTator, text mining | PubMed |
| Spatially Guided and Single Cell Tools to Map the Microenvironment in Cutaneous T-Cell Lymphoma. | Cancers (Basel) | 2023 | 37190290 | PubTator, text mining | PubMed |
| Hypoxia-inducible factor-1α regulates the interleukin-6 production by B cells in rheumatoid arthritis. | Clin Transl Immunology | 2023 | 37179532 | PubTator, text mining | PubMed |
| B-Cell Receptor Signaling Is Thought to Be a Bridge between Primary Sjogren Syndrome and Diffuse Large B-Cell Lymphoma. | Int J Mol Sci | 2023 | 37176092 | PubTator, text mining | PubMed |
| Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases. | Int J Mol Sci | 2023 | 37175894 | PubTator, text mining | PubMed |
| Retrospective Case-Control Study Genes Related to Bone Metabolism That Justify the Condition of Periodontal Disease and Failure of Dental Implants in Patients with down Syndrome. | Int J Mol Sci | 2023 | 37175429 | PubTator, text mining | PubMed |
| Identification of potential resistance mechanisms and therapeutic targets for the relapse of BCMA CAR-T therapy in relapsed/refractory multiple myeloma through single-cell sequencing. | Exp Hematol Oncol | 2023 | 37158921 | PubTator, text mining | PubMed |
| Dynamin-related protein 2 interacts with the membrane-associated methyltransferase domain of plantago asiatica mosaic virus replicase and promotes viral replication. | Virus Res | 2023 | 37149224 | PubTator, text mining | PubMed |
| A human model of asthma exacerbation reveals transcriptional programs and cell circuits specific to allergic asthma. | Sci Immunol | 2023 | 37146132 | PubTator, text mining | PubMed |
| Small heterodimer partner interacting leucine zipper protein (SMILE) ameliorates autoimmune arthritis via AMPK signaling pathway and the regulation of B cell activation. | Cell Commun Signal | 2023 | 37143079 | PubTator, text mining | PubMed |
| Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD. | JCI Insight | 2023 | 37129971 | PubTator, text mining | PubMed |
| The role of group 3 innate lymphoid cell in intestinal disease. | Front Immunol | 2023 | 37122757 | PubTator, text mining | PubMed |
| Antigen-specificity measurements are the key to understanding T cell responses. | Front Immunol | 2023 | 37122719 | PubTator, text mining | PubMed |
| Innate Immune Recognition, Integrated Stress Response, Infection, and Tumorigenesis. | Biology (Basel) | 2023 | 37106700 | PubTator, text mining | PubMed |
Safety and immunogenicity of ETVAX®, an oral inactivated vaccine against enterotoxigenic Escherichia coli diarrhoea: a double-blinded, randomized, placebo-controlled trial amongst Finnish travellers to Benin, West Africa. | J Travel Med | 2023 | 37099803 | PubTator, text mining | PubMed |
| ProgClust: A progressive clustering method to identify cell populations. | Front Genet | 2023 | 37091787 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4050/papers?page=14